2026 data Public-data reference. official source

SPECTRUM PHARMACEUTICALS INC

Open-data reference.

Chemicals & Pharmaceuticals · DE · FY2021
CEO-to-Worker Pay Ratio
18:1
Below Average (Scale: 0–1000:1)
CEO Pay
N/A
Median Worker
N/A
Compensation Pillar

CEO compensation breakdown — pay ratio 18× median worker (Dodd-Frank §953(b) disclosure)

CompensationBase salaryBonusEquityPerksPension
CEO compensation breakdown — pay ratio 18× median worker (Dodd-Frank §953(b) disclosure)

SPECTRUM PHARMACEUTICALS INC, a chemicals & pharmaceuticals company, reported a CEO-to-worker pay ratio of 18:1 in FY2021. CEO received total compensation of N/A, while the median employee earned N/A annually. This is below the Chemicals & Pharmaceuticals industry median of 44:1 across 185 companies. Data sourced from SEC EDGAR proxy (DEF 14A) filings.

CEO Compensation Breakdown — FY2021

Detailed breakdown not available.

CEO compensation components for SPECTRUM PHARMACEUTICALS INC in fiscal year 2021 as disclosed on SEC EDGAR Form DEF 14A.
Component Amount (USD)
Base Salary
Bonus
Stock Awards
Option Awards
Non-Equity Incentive Plan
Pension Value Change
Other Compensation
Total Compensation

Source: SEC EDGAR Form DEF 14A — CIK 831547, FY2021 Summary Compensation Table.

Industry Comparison — Chemicals & Pharmaceuticals

This Company's Ratio
18:1
Industry Median Ratio
44:1
Industry Median CEO Pay
$7.8M
This CEO's Pay
N/A
Companies in Industry
185
vs. Industry Median
Below
View all companies in Chemicals & Pharmaceuticals →

Understanding This Pay Ratio

SPECTRUM PHARMACEUTICALS INC's CEO-to-worker pay ratio of 18:1 means that earned 18 times more than the company's median employee in FY2021.

The median employee at SPECTRUM PHARMACEUTICALS INC earned N/A annually. At that wage, it would take a median employee approximately 18 years to earn what the CEO earned in a single year.

CEO Total Pay

N/A

FY2021 Summary Compensation

Pay Ratio

18:1

Below typical industry median

Disclosure Transparency

1.0/5

Limited pay component reporting

Pay-Versus-Performance Disclosure

Under 17 CFR §229.402(v) (the Pay-Versus-Performance rule effective for fiscal years ending after December 16, 2022), issuers must reconcile Compensation Actually Paid (CAP) to Total Shareholder Return (TSR) over a multi-year window. The chart below visualizes the relationship between SPECTRUM PHARMACEUTICALS INC's reported CAP and TSR for FY2021.

Pay vs Performance — FY2021 (Dodd-Frank §953(a) PvP disclosure)

TSR (%)0CAP realized ($M)0CAP granted ($M)0
Pay vs Performance — FY2021 (Dodd-Frank §953(a) PvP disclosure)

What This 2021 Filing Tells Us About SPECTRUM PHARMACEUTICALS INC

According to the 2021 DEF 14A proxy statement filed with the SEC, SPECTRUM PHARMACEUTICALS INC (, CIK 831547) reported CEO 's total compensation at N/A. That figure is an aggregate of base salary (N/A). The median employee at the firm — the reference point mandated by Section 953(b) of the Dodd-Frank Act — earned N/A over the same fiscal year, producing the headline CEO-to-worker pay ratio of 18:1 that this page tracks.

Context matters when reading this ratio. SPECTRUM PHARMACEUTICALS INC operates in the Chemicals & Pharmaceuticals sector and is headquartered in DE. Across the Chemicals & Pharmaceuticals industry (SIC 28), 185 SEC-reporting companies disclosed pay ratios in FY2023, with a median of 44:1 and an average of 90:1. Median industry CEO pay was $7.8M, so SPECTRUM PHARMACEUTICALS INC's N/A sits at or below that typical figure. That comparison is the fastest way to separate "the CEO is paid like peers" from "this company is an outlier."

Finally, a note on what these SEC numbers do and do not include. Total compensation reported under Item 402 of Regulation S-K reflects grant-date fair value for equity awards, not realized pay, so a CEO may eventually cash in more — or less — depending on stock performance and vesting. The pay ratio itself is calculated against a single median employee chosen under rules that allow statistical sampling, and companies may update methodology year to year. This proxy was filed on 2022-04-27; all figures on this page come directly from that public filing and can be verified against the DEF 14A on the SEC EDGAR system.

Key Data — FY2021

CEO
Total Compensation
N/A
Base Salary
N/A
Median Employee Pay
N/A
Pay Ratio
18:1
Filing Date
2022-04-27

Company Info

Ticker
CIK
831547
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
DE
Data Source: This data is sourced from SEC EDGAR proxy statement (DEF 14A) filings. PlainCEOPay provides this publicly available information for informational purposes only. Not investment or financial advice. Verify with official SEC filings at sec.gov.

Frequently Asked Questions

What is the CEO pay ratio at SPECTRUM PHARMACEUTICALS INC?
SPECTRUM PHARMACEUTICALS INC's CEO-to-worker pay ratio is 18:1. CEO null earned N/A in FY2021, while the median employee earned N/A.
How much does SPECTRUM PHARMACEUTICALS INC's CEO earn?
null, CEO of SPECTRUM PHARMACEUTICALS INC (null), earned total compensation of N/A in fiscal year 2021, according to SEC proxy filings.
How does SPECTRUM PHARMACEUTICALS INC's pay ratio compare to its industry?
SPECTRUM PHARMACEUTICALS INC's pay ratio of 18:1 is below the Chemicals & Pharmaceuticals industry median of 44:1. The industry has 185 companies reporting pay ratios.
Where does SPECTRUM PHARMACEUTICALS INC's CEO pay data come from?
All executive compensation data is sourced from SEC EDGAR DEF 14A proxy statement filings. Companies are required by the Dodd-Frank Act to disclose CEO-to-median-worker pay ratios annually. PlainCEOPay aggregates this publicly available data for easy comparison.
What is included in null's total compensation?
Total compensation of N/A includes base salary, stock awards, option awards, non-equity incentive plan compensation, pension value changes, and other compensation as reported in the proxy filing summary compensation table.
How long would it take a median SPECTRUM PHARMACEUTICALS INC employee to earn the CEO's pay?
At a median salary of N/A, it would take the typical SPECTRUM PHARMACEUTICALS INC employee approximately 18 years to earn what CEO null earned in a single year (N/A in FY2021).
All federal data sources used on this page

Related

Data sourced from $official public datasets. See our methodology for details. Retrieved and formatted by PlainCEOPay Editorial